Affinity CSL627_3001


Study NameStudy TitleStudy TypeSponsorSponsor Type
Affinity CSL627_3001A Phase III Open-label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII-SinglChain, CSL627) in Subjects with Severe Hemophilia AClinical TrialCSL BehringIndustry Sponsored